SNRE:NSD-SNRE (USD)

COMMON STOCK | Other |

Last Closing

USD 43.34

Change

-0.34 (-0.78)%

Market Cap

USD 4.33B

Volume

0.17M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
WOOF Pet Acquisition LLC

-0.06 (-1.50%)

USD 7.56B
JSM Navient Corporation SR NT 6% 1..

-0.14 (-0.74%)

USD 5.34B
BHFAL Brighthouse Financial Inc

-0.22 (-0.91%)

USD 4.97B
RGC Regencell Bioscience Holdings ..

+0.40 (+8.45%)

USD 3.60B
OB Outbrain Inc

+0.22 (+2.98%)

USD 1.71B
RILYG B. Riley Financial Inc. 5.00% ..

-0.12 (-0.98%)

USD 0.54B
RILYZ B. Riley Financial Inc. 5.25% ..

-0.07 (-0.77%)

USD 0.54B
NEWTZ Newtek Business Services Corp...

-0.04 (-0.16%)

USD 0.45B
NEWTI NewtekOne, Inc. 8.00% Fixed Ra..

+0.24 (+0.96%)

USD 0.43B
GAINN Gladstone Investment Corporati..

+0.05 (+0.20%)

USD 0.39B

ETFs Containing SNRE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 4.33B 84% B 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.